Personalized Support for Progress (PSP) for Anxiety

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Anxiety+3 More
Personalized Support for Progress (PSP) - Other
Eligibility
18+
Female
What conditions do you have?
Select

Study Summary

This trial will help researchers understand how to better provide mental health care and social resources to rural veteran women, especially those of color, who are in distress and have unmet needs.

Eligible Conditions
  • Anxiety
  • Psychological Distress
  • Post Traumatic Stress Disorder (PTSD)
  • Depression

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

2 Primary · 10 Secondary · Reporting Duration: 6 Months (post-intervention) and 9 Months (3 Months post-intervention)

Month 9
Veteran satisfaction
Month 9
Autonomy Support
Change in Perception of Quality of Life
Post-Traumatic Stress Disorder
Change in actual engagement with social resource services and mental health treatment
Change in anxiety symptoms
Change in depression symptoms
Change in functioning
Change in greater perceived progress on needs
Change in perceived access to social resource services and mental health treatment
Change in perceived stress
Change in social needs
Perceived Confidence
Stigma-related beliefs about mental health
Therapeutic alliance

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Tailored Referral (TR)
1 of 2
Personalized Support for Progress (PSP)
1 of 2

Active Control

Experimental Treatment

72 Total Participants · 2 Treatment Groups

Primary Treatment: Personalized Support for Progress (PSP) · No Placebo Group · N/A

Personalized Support for Progress (PSP)
Other
Experimental Group · 1 Intervention: Personalized Support for Progress (PSP) · Intervention Types: Other
Tailored Referral (TR)
Other
ActiveComparator Group · 1 Intervention: Tailored Referral (TR) · Intervention Types: Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 6 months (post-intervention) and 9 months (3 months post-intervention)

Who is running the clinical trial?

Syracuse VA Medical CenterLead Sponsor
12 Previous Clinical Trials
1,060 Total Patients Enrolled
US Department of Veterans AffairsFED
853 Previous Clinical Trials
470,799 Total Patients Enrolled
4 Trials studying Anxiety
196 Patients Enrolled for Anxiety
Ellen Poleshuck, PhDPrincipal InvestigatorSyracuse VA Medical Center
2 Previous Clinical Trials
283 Total Patients Enrolled
Derrecka Boykin, PhDPrincipal InvestigatorMichael E. DeBakey Medical Center

Eligibility Criteria

Age 18+ · Female Participants · 10 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
Aim 1 - Identify the needs of women Veterans with PSP.
You are a VHA provider and you are employed by the VHA.
You are able to communicate in English.
You have experienced psychological distress in the past 6 months as evidenced by a diagnosis in the electronic health record or elevated score on the PHQ-9, GAD-7 and/or PCL.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 14th, 2021

Last Reviewed: November 18th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

References